On June 1, 2006, Rose Biomedical Development Corporation went out of business, and is selling its IP. Rose Biomedical (RB) works with partners to develop and commercialize technology that can lead to improvements in the quality of patient care, while reducing medical costs. RB assists partners in securing resources to successfully build, test and commercialize medical products and accelerate the time to market to benefit healthcare professionals and patients
